🇪🇬 Egypt Clinical Trials Database
Search 12,000+ clinical trials conducted in Egypt. Access comprehensive trial data including phases, sponsors, outcomes, and locations from International Registries. Part of Pure Global AI's free database with 840,000+ trials worldwide.
What is the Egypt clinical trials database?
The Egypt clinical trials database contains over 12,000 clinical trials registered through international registries. It includes trials for drugs, medical devices, biologics, and behavioral interventions conducted in Egypt.
How do I search for clinical trials in Egypt?
Enter a disease name, drug name, sponsor, or trial ID in the search box above. You can filter results by phase, status, and intervention type.
What information is available for each trial?
Each trial listing includes: trial ID, study title, phase, status, sponsor, enrollment, start/end dates, disease/condition, intervention, primary outcomes, and location information.
Is this database free to use?
Yes, this database is completely free. Pure Global AI provides free access to clinical trial data to help researchers, patients, and companies find relevant clinical research in Egypt.
How often is the database updated?
The database aggregates data from international registries and is updated regularly. The full database contains 840,000+ trials from 20+ registries worldwide.
What regulatory body oversees clinical trials in Egypt?
The Egyptian Drug Authority (EDA) oversees clinical trials in Egypt.
What types of trials are common in Egypt?
Egypt is the largest pharmaceutical market in Africa and the Middle East, with growing clinical research infrastructure.
About This Database
This database provides free access to clinical trial data from Egypt. Data is aggregated from international registries and international registries. Use this tool to research ongoing trials, find recruitment opportunities, analyze competitive landscape, and track drug/device development. Egypt offers access to a large patient population and is a key market in the MENA region.